COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: www.coronavirus.gov
Get the latest research information from NIH: www.nih.gov/coronavirus

The NIH intramural research program has shifted all non-mission-critical laboratory operations to a maintenance phase in order to promote physical distancing and diminished transmission risk of COVID-19. Effective Monday, March 23, 2020, only mission-critical functions within NIH research laboratories will be supported.

Clinical Research Section

of the Liver Diseases Branch

T. Jake Liang, M.D., NIH Distinguished Investigator

Section Chief

jake.liang@nih.gov

A group of physician-scientists investigating the pathogenesis, natural history, and novel therapeutics for a wide range of liver diseases.

About Our Research

Select Publications

Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly.: Li Q, Pène V, Krishnamurthy S, Cha H, Liang TJ.; Nat Med (2013 Jun) 19:722-9. Abstract/Full Text
Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model.: Carpentier A, Tesfaye A, Chu V, Nimgaonkar I, Zhang F, Lee SB, Thorgeirsson SS, Feinstone SM, Liang TJ.; J Clin Invest (2014 Nov) 124:4953-64. Abstract/Full Text

View More Publications

Lab Members

Photo of the Clinical Research Section staff.

View Our Lab Members

Clinical Trials Research Materials